Showing results (491-500 of 2,398) with videos related to

Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|July 20, 2025
Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosisYuko Ueki, Yoshiya Horimoto, Kazuharu Harada, et al.
Breast Cancer (Tokyo, Japan)|June 25, 2025
Validation of the predictive ability for recurrence and the clinical utility of the 95-gene classifier (95GC) through an integrated analysis of five studiesAya Imai, Ryo Tsunashima, Yu Hidaka, et al.
Breast Cancer (Tokyo, Japan)|July 15, 2025
Major anatomic variations of the lateral upper arm lymphatic pathway in a healthy female populationJames E Fanning, Madeleine Givant, Angela Chen, et al.
Breast Cancer (Tokyo, Japan)|June 24, 2025
KLF13 promotes breast cancer progression through the HTRA1 and the Hedgehog signaling pathwayMeiling Huang, Jian Zhang, Changjiao Yan, et al.
Breast Cancer (Tokyo, Japan)|December 4, 2025
Two breasts, one breath: continuous positive airway pressure for innovative heart sparing in synchronous bilateral breast cancer radiotherapyZeineb Naimi, Amal Riahi, Azza Slim, et al.
Breast Cancer (Tokyo, Japan)|December 27, 2024
Clinicopathological significance of androgen receptor expression and tumor infiltrating lymphocytes in triple-negative breast cancer: a retrospective cohort studyTakeshi Ushigusa, Nami Hirakawa, Yuka Kajiura, et al.
Breast Cancer (Tokyo, Japan)|December 18, 2024
Prognostic impact of tumor‑associated stroma in triple-negative breast cancerAkinari Kakumoto, Tsengelmaa Jamiyan, Ai Koyanagi, et al.
Breast Cancer (Tokyo, Japan)|February 12, 2025
Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgeryYuka Matsubara, Nobuyasu Suganuma, Shogo Nakamoto, et al.
Breast Cancer (Tokyo, Japan)|January 31, 2025
NELBI score: a new clinical calculator of thirty-day mortality following systemic anticancer therapy in breast cancer patients near the end of lifeTuğba Önder, Cengiz Karaçin
Breast Cancer (Tokyo, Japan)|February 18, 2025
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancerReiki Nishimura, Yasuaki Sagara, Reiko Mitsueda, et al.
Pageof 240